Using low frequency magnetic fields to heat nanoparticles for cancer treatment
Heating Magnetic Nanoparticles using Low Frequency Ferromagnetic Resonance
This study is exploring a new way to help cancer treatments work better by using low-frequency magnetic fields to heat tiny magnetic particles, which could make treatments like heat therapy safer and more effective for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dartmouth-Hitchcock Clinic NIH-funded |
| Lab location | 1 site (Lebanon, United States) |
| Project ID | NIH-11035505 on NIH RePORTER |
What this research studies
This research investigates a novel approach to cancer therapy by using low frequency magnetic fields to heat magnetic nanoparticles. The goal is to enhance the effectiveness of cancer treatments that rely on heat, such as ablation and drug release, while minimizing damage to surrounding healthy tissues. By delivering pulsed radio frequency fields at the ferromagnetic resonance frequency of the nanoparticles, the researchers aim to efficiently deposit energy into the nanoparticles without overheating normal tissues. This method could potentially improve the precision and safety of cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research would be patients with specific types of cancer that are amenable to heat-based therapies.
Not a fit: Patients with cancers that do not respond to heat-based treatments or those who are not eligible for such therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer cancer treatments that target tumors while sparing healthy tissues.
How similar studies have performed: Other research has shown promise in using magnetic nanoparticles for cancer treatment, but this specific approach using low frequency fields is relatively novel.
Where this research is happening
Lebanon, United States
- Dartmouth-Hitchcock Clinic — Lebanon, United States (Active)
Researchers
- Principal investigator: Weaver, John B — Dartmouth-Hitchcock Clinic
- Study coordinator: Weaver, John B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.